Clinical trial
Dopamine and Norepinephrine in Shock Patients
NCT00314704 · Sepsis Occurrence in Acutely Ill Patients, Other · Completed
Key facts
| NCT number | NCT00314704 |
|---|---|
| Title | Dopamine and Norepinephrine in Shock Patients |
| Official title | Comparison of Dopamine and Norepinephrine as the First Vasopressor Agent in the Management of Shock |
| Lead sponsor | Sepsis Occurrence in Acutely Ill Patients, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Shock |
| Intervention type | Drug |
| Interventions | dopamine versus norepinephrine |
| Enrollment | 1,679 |
| Start date | Dec 1, 2003 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Apr 14, 2006 |
| Last update posted | Feb 1, 2010 |
| Countries | Austria, Belgium, Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: